Dayong Gu Chief Physician
SZU First Affiliated Hospital
Chief Physician
Clinical Laboratory Medicine
SZU First Affiliated Hospital
Chief Physician
Clinical Laboratory Medicine
BIOGRAPHICAL SKETCH
NAME: Dayong Gu
POSITION TITLE: Chief Physician
EDUCATION/TRAINING
A. Personal statement
I have decades of experience conducting clinical examinations related to the monitoring and detection of infectious diseases, and extensive additional experience researching immune response mechanisms to viruses, biochip technology and sensor technology based on rapid, high-throughput detection of microorganisms. As a director of the Clinical Laboratory Department at the First Affiliated Hospital of Shenzhen University, I completed a number of research projects funded by national, military, provincial and municipal institutions; including the National Keypoint Research and Invention Program of the Thirteenth, Chinese National Programs for High Technology Research and Development, and the National Nature Science Foundation of China. I also became a Master’s tutor and a postdoctoral advisor. In terms of research results and awards, I have obtained 33 authorized invention patents, two software copyrights and over 100 papers (with more than 30 of these being SCI indexed). I participated in the completion of six books as an editor-in-chief, a translator, and as a participant. I am honored to have won 13 science and technology awards during my career, and completed 12 national and industrial standards.
I have also held multiple social positions, as follows.
Standing Member of the Basic Level Inspection Technology Standardization Branch of CPAM (China International Exchange and Promotive Association for Medical and Health Care).
Member of the Group Committee of Quarantine Microbiology, Special Committee of Zoonosis of CSM (Chinese Society of Microbiology).
Member of the Air Microbiology Group of the Health Inspection Committee of the Chinese Preventive Medicine Association.
Young Member of the Editorial Committee of “Chinese Journal of Laboratory Medicine”.
Vice Chairman of the Sensing Technology Branch of Guangdong Society of Biomedical Engineering.
Vice President of Guangdong Society of Tropical Medicine.
Executive Director of Guangdong Parasite Society.
Member of the Medical Laboratory Branch of Guangdong Medical Association.
Member of the Standing Committee of the Branch of Laboratory Physicians of Guangdong Medical Association.
Member of the Shenzhen Public Health Emergency Expert Group.
Vice Chairman of the Integrated Medicine Committee of Shenzhen Hospital Managers Association.
B. Positions and honors
Positions
1994-1998: House Physician, Laboratory of the First Sanatorium of Qingdao, Jinan Military Region, China
2004: Associate Chief Physician, Laboratory of the 401st Hospital of Jinan Military Region, China
2007-2013: Associate Chief Physician, Shenzhen Entry Exit Inspection and Quarantine Bureau, China
2013: Visiting Scholar, Lehigh University, PA, USA
2013-2019: Chief Physician, Shenzhen Entry Exit Inspection and Quarantine Bureau, China
2019-present: Chief Physician, Laboratory of Shenzhen Second People's Hospital, China
C. Representative publications (selected from the past five years 5-10篇)
1.Li Song, Wei Li, Jian’an He, Lang Li, Tao Li, Dayong Gu* and Huanwen Tang** (2020) Development of a Pulsed Xenon Ultraviolet Disinfection Device for Real-Time Air Disinfection in Ambulances. Journal of Healthcare Engineering, Article ID: 6053065.
2.Wei Wang#, Rui-ling Dong#, Dayong Gu#, Jian’an He#, Pin Yib, Siu-Kai Kong, Ho-Pui Ho, Jacky Fong-Chuen Loo*, Wen Wang** and Qian Wang (2020) Antibody-free rapid diagnosis of malaria in whole blood with surface-enhanced Raman Spectroscopy using Nanostructured Gold Substrate. Advances in Medical Sciences, 65(1): 86-92.
3.Lang Li#, Jian’an He#, Wei Wang#, Yun Xia, Song Li, Ze-han Chen, Hang-zhi Zuo, Xuan-Ping Tan, Aaron Ho-Pui Ho, Siu-Kai Kong, Jacky Fong-Chuen Loo*, Hua-wen Li* and Dayong Gu* (2019) Development of a direct reverse-transcription quantitative PCR (dirRT-qPCR) assay for clinical Zika diagnosis. International Journal of Infectious Diseases, 85: 167-174.
4.Wei Wang#, Ruiling Dong#, Yong Guo, Jian’an He, Chaopeng Shao, Pin Yi, Fujun Yu*, Dayong Gu* and Jianjian Zheng** (2019) CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7. Journal of Cellular and Molecular Medicine, 23(8): 5486-549.
5.Tianchuan Zhu#, Jian’an He#, Wanshan Chen, Ho-Pui Ho, Siu-Kai Kong, Chenlong Wang, Jun Long*, Jacky Fong-Chuen Loo** and Dayong Gu*** (2018) Development of peptide-based chemiluminescence enzyme immunoassay (CLEIA) for diagnosis of dengue virus infection in human. Analytical Biochemistry, 1(556):112-118.
D. Research support
Ongoing projects (RMB)
基金英文名 (项目编号) 01/01/2018 to 12/31/2022
负责人英文名, PI ¥金额
Shenzhen Science and Technology R & D Fund (Shenzhen Hong Kong Innovation Circle joint R & D project) (SGLH20180625171602058) 2019 to 2022
PI: Dayong Gu ¥ 2,000,000
National Key R&D Project (2018YFC0809200) 30/06/2018 to 01/07/2021
PI: Dayong Gu ¥2,970,000
用户登录
还没有账号?
立即注册